Page last updated: 2024-10-31

moclobemide and Chemical Dependence

moclobemide has been researched along with Chemical Dependence in 4 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
"Serotonin syndrome is a potentially life-threatening complication of psychopharmacological drug therapy."2.40Serotonin syndrome and drug combinations: focus on MAOI and RIMA. ( Hilton, SE; Maradit, H; Möller, HJ, 1997)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Hung, CC1
Lee, CH1
Ko, AM1
Lane, HY1
Lee, CP1
Ko, YC1
Hilton, SE1
Maradit, H1
Möller, HJ1
Montgomery, SA1
Wesnes, K1
Anand, R1
Lorscheid, T1

Reviews

2 reviews available for moclobemide and Chemical Dependence

ArticleYear
Serotonin syndrome and drug combinations: focus on MAOI and RIMA.
    European archives of psychiatry and clinical neuroscience, 1997, Volume: 247, Issue:3

    Topics: Autonomic Nervous System Diseases; Benzamides; Brain Stem; Drug Therapy, Combination; Humans; Moclob

1997
Social phobia: diagnosis, severity and implications for treatment.
    European archives of psychiatry and clinical neuroscience, 1999, Volume: 249 Suppl 1

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Behavior Therapy; Benzamides; Benzodiazepines; Child

1999

Trials

2 trials available for moclobemide and Chemical Dependence

ArticleYear
Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial.
    Epidemiology and psychiatric sciences, 2020, May-06, Volume: 29

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Areca; Asian People; Citalopram; Double-Blind Method

2020
Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of aging and dementia.
    Acta psychiatrica Scandinavica. Supplementum, 1990, Volume: 360

    Topics: Adult; Alzheimer Disease; Antidepressive Agents; Attention; Benzamides; Cognition; Dose-Response Rel

1990